Primary Progressive Multiple Sclerosis Treatment Market Report

China Primary Progressive Multiple Sclerosis Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：219
  • REPORT CODE：GMM1776347
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Primary Progressive Multiple Sclerosis Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Santhera Pharmaceuticals Holding AG

    • Genzyme Corporation

    • MedDay SA

    • F Hoffmann-La Roche Ltd

    • Glialogix, Inc

    • Kyorin Pharmaceutical Co, Ltd

    By Type:

    • Idebenone

    • Ibudilast

    • GZ-402668

    • Laquinimod Sodium

    • Others

    • Biotin

    By Application:

    • Clinic

    • Others

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Primary Progressive Multiple Sclerosis Treatment Market Overview 2018-2029

    • 1.1 China Primary Progressive Multiple Sclerosis Treatment Industry Development Overview

    • 1.2 China Primary Progressive Multiple Sclerosis Treatment Industry Development History

    • 1.3 China Primary Progressive Multiple Sclerosis Treatment Industry Market Size (2018-2029)

    • 1.4 China Primary Progressive Multiple Sclerosis Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Idebenone (2018-2029)

      • 1.4.2 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Ibudilast (2018-2029)

      • 1.4.3 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of GZ-402668 (2018-2029)

      • 1.4.4 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Laquinimod Sodium (2018-2029)

      • 1.4.5 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.6 China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Biotin (2018-2029)

    • 1.5 China Primary Progressive Multiple Sclerosis Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Primary Progressive Multiple Sclerosis Treatment Market Analysis by Region

      • 1.6.1 North China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Primary Progressive Multiple Sclerosis Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Primary Progressive Multiple Sclerosis Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Primary Progressive Multiple Sclerosis Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Primary Progressive Multiple Sclerosis Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Primary Progressive Multiple Sclerosis Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Primary Progressive Multiple Sclerosis Treatment Industry Development

    Chapter 3 Primary Progressive Multiple Sclerosis TreatmentIndustry Chain Analysis

    • 3.1 Primary Progressive Multiple Sclerosis Treatment Industry Chain

    • 3.2 Primary Progressive Multiple Sclerosis Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Primary Progressive Multiple Sclerosis Treatment Market

    • 3.3 Primary Progressive Multiple Sclerosis Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Primary Progressive Multiple Sclerosis Treatment Market

    Chapter 4 China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 4.1 China Primary Progressive Multiple Sclerosis Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Primary Progressive Multiple Sclerosis Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Idebenone

      • 4.5.2 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Ibudilast

      • 4.5.3 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of GZ-402668

      • 4.5.4 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Laquinimod Sodium

      • 4.5.5 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Others

      • 4.5.6 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Biotin

    Chapter 5 China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Primary Progressive Multiple Sclerosis Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Clinic

      • 5.5.2 China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Others

      • 5.5.3 China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Hospital

    Chapter 6 China Primary Progressive Multiple Sclerosis Treatment Market, by Region

    • 6.1 China Primary Progressive Multiple Sclerosis Treatment Production Volume and Production Value, by Region

    • 6.2 China Primary Progressive Multiple Sclerosis Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 7.1 North China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 7.2 North China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 8 Central China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 8.1 Central China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 8.2 Central China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 9 South China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 9.1 South China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 9.2 South China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 10 East China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 10.1 East China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 10.2 East China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 11 Northeast China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 11.1 Northeast China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 11.2 Northeast China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 12 Southwest China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 12.1 Southwest China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 12.2 Southwest China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 13 Northwest China Primary Progressive Multiple Sclerosis Treatment Market Analysis

    • 13.1 Northwest China Primary Progressive Multiple Sclerosis Treatment Market, by Type

    • 13.2 Northwest China Primary Progressive Multiple Sclerosis Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Santhera Pharmaceuticals Holding AG

        • 14.1.1 Santhera Pharmaceuticals Holding AG Company Profile

        • 14.1.2 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Genzyme Corporation

        • 14.2.1 Genzyme Corporation Company Profile

        • 14.2.2 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 MedDay SA

        • 14.3.1 MedDay SA Company Profile

        • 14.3.2 MedDay SA Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 F Hoffmann-La Roche Ltd

        • 14.4.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.4.2 F Hoffmann-La Roche Ltd Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Glialogix, Inc

        • 14.5.1 Glialogix, Inc Company Profile

        • 14.5.2 Glialogix, Inc Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Kyorin Pharmaceutical Co, Ltd

        • 14.6.1 Kyorin Pharmaceutical Co, Ltd Company Profile

        • 14.6.2 Kyorin Pharmaceutical Co, Ltd Primary Progressive Multiple Sclerosis Treatment Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Primary Progressive Multiple Sclerosis Treatment Industry Research Conclusions

    • 15.2 Primary Progressive Multiple Sclerosis Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Primary Progressive Multiple Sclerosis Treatment Industry Market Size (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Idebenone (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Ibudilast (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of GZ-402668 (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Laquinimod Sodium (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume, Production Value and Growth Rate of Biotin (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate from 2018-2029

    • Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2018

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Share by Type in 2023

    • Figure China Primary Progressive Multiple Sclerosis Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Idebenone (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Ibudilast (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of GZ-402668 (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Laquinimod Sodium (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume and Growth Rate of Biotin (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2018

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Share by Application in 2023

    • Figure China Primary Progressive Multiple Sclerosis Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Others (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Production Volume by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Region (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Production Value by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Production Value Share by Region (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Production Value Share by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Sales Value by Region (2018-2023)

    • Table China Primary Progressive Multiple Sclerosis Treatment Sales Value Share by Region (2018-2023)

    • Figure China Primary Progressive Multiple Sclerosis Treatment Sales Value Share by Region (2018-2023)

    • Table North China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table North China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table North China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table North China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table Central China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table Central China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table South China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table South China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table South China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table East China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table East China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table East China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Primary Progressive Multiple Sclerosis Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Primary Progressive Multiple Sclerosis Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Primary Progressive Multiple Sclerosis Treatment Sales Volume Share by Application (2018-2023)

    • Table Santhera Pharmaceuticals Holding AG Company Profile

    • Table Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)

    • Table Genzyme Corporation Company Profile

    • Table Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)

    • Table MedDay SA Company Profile

    • Table MedDay SA Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)

    • Table Glialogix, Inc Company Profile

    • Table Glialogix, Inc Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)

    • Table Kyorin Pharmaceutical Co, Ltd Company Profile

    • Table Kyorin Pharmaceutical Co, Ltd Primary Progressive Multiple Sclerosis Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US